Jiangxi Institute of Biological Products Inc. (HKG:6915)

Hong Kong · Delayed Price · Currency is HKD

10.74

+0.45 (4.37%)

At close: Oct 7, 2026

HKG:6915 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	219	235.41	220.76	198.02
Revenue Growth	10.59%	6.64%	11.48%	-
Gross Profit	166.67	180.69	155.14	134.31
Operating Income	86.72	101.28	82.5	48.04
Net Income	72.32	94.79	75.14	55.49
Earnings Per Share	0.26	0.35	0.28	0.20
EPS Growth	28.93%	26.16%	35.40%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Chinese Mainland	206.05	222.98	212.73	195
Overseas	12.95	12.43	8.02	3.02
Total	219	235.41	220.76	198.02

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	417.21	74.11	57.15	58.28
Total Debt	1.01	0.89	0.72	21.12
Net Cash (Debt)	416.2	73.22	56.43	37.16
Net Cash Growth	1020.05%	29.74%	51.87%	-
Net Cash Per Share	1.53	0.27	0.21	0.14

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	62.78	56.83	104.06	68.61
Capital Expenditures	-33.4	-36.04	-16.64	-30.42
Free Cash Flow	29.39	20.79	87.41	38.19
Free Cash Flow Growth	-23.05%	-76.22%	128.91%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	76.11%	76.75%	70.28%	67.82%
Operating Margin	39.60%	43.03%	37.37%	24.26%
Pretax Margin	37.84%	46.41%	41.57%	32.11%
Profit Margin	33.02%	40.27%	34.04%	28.02%
FCF Margin	13.42%	8.83%	39.60%	19.28%